References
- Kirsner RS, Federman DG. Managed care: the dermatologist as a primary care provider. J Am Acad Dermatol 1995; 33(3): 535–7
- Stern RS, Johnson ML, DeLozier J. Utilization of physician services for dermatologie complaints: the United States, 1974. Arch Dermatol 1977; 113(8): 1062–6
- Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25(11): 1271–7
- Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979; 115(12):1409–15
- Plotz PH, Dalakas M, Leff RL, et al. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989; 111(2):143–57
- Basset-Seguin N, Roujeau JC, Gherardi R, et al. Prognostic factors and predictive signs of malignancy in adult dermatomyositis: a study of 32 cases. Arch Dermatol 1990; 126(5):633–7
- Woo TY, Callen JP, Voorhees JJ, et al. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 1984; 10(4):592–600
- Falanga V, Medsger TA, Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 1987; 123(3): 350–3
- Moreland LW, Brick JE, Kovach RE, et al. Acute febrile neutrophilic dermatosis (Sweet syndrome): a review of the literature with emphasis on musculoskeletal manifestations. Semin Arthritis Rheum 1988; 17(3):143–53
- Klock JC, Oken RL. Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer 1976; 37(2):922–7
- Callen JP. Pyoderma gangrenosum and related disorders. Med Clin North Am 1989; 73(5):1247–61
- Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum: review of 21 cases. Arch Dermatol 1989; 125(1):57–64
- Matis WL, Ellis CN, Griffiths CE, et al. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992; 128(8):1060–4
- Lowe NJ. Systemic treatment of severe psoriasis: the role of cyclosporine. (Editorial) N Engl J Med 1991; 324(5):333–4
- Lotem M, Katzenelson V, Rotem A, et al. Impetigo herpetiformis: a variant of pustular psoriasis or a separate entity? J Am Acad Dermatol 1989; 20(2 Pt 2):338–41
- Baker H. Epidemiological aspects of psoriasis and arthritis. Br J Dermatol 1966; 78:249–61
- Kerdel FA, Moschella SL. Sarcoidosis: an updated review. J Am Acad Dermatol 1984; 11(1):1–19
- Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339(8800): 1012–5
- Zie JA, Horowitz DH, Arzubiaga C, et al. Treatment of cutaneous sarcoidosis with chloroquine: review of the literature. Arch Dermatol 1991; 127(7):1034–40
- Howland WW, Golitz LE, Weston WL, et al. Erythema multiforme: clinical, histopathologic, and immunologic study. J Am Acad Dermatol 1984; 10(3):438–46
- Lawley TJ, Kubota Y. Vasculitis. Dermatol Clin 1990; 8(4):681–7
- Lever WF. Pemphigus and pemphigoid: a review of the advances made since 1964. J Am Acad Dermatol 1979; 1 (1):2–31
- Korman N. Bullous pemphigoid. J Am Acad Dermatol 1987;16(5 Pt 1):907–24
- Thomas I, Khorenian S, Arbesfeld DM. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 1993; 28(1):74–7
- Stanley JR. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 1993; 53:291–325
- Steere AC. Lyme disease. N Engl J Med 1989; 321(9):586–96
- Abele DC, Anders KH. The many faces and phases of borreliosis. I. Lyme disease. J Am Acad Dermatol 1990; 23(2 Pt 1): 167–86 [Erratum, J Am Acad Dermatol 1991; 24(4):663]
- Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123(8):615–20